Assessment of Sleep Disturbance and Sleep Disordered Breathing in Primary Immunodeficiency Disorders

Overview

About this study

The purpose of this research is to understand sleep disturbances in patients with primary immunodeficiency.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

≥ 18 years of age.
Physician diagnosed primary immunodeficiency disorder.
Computer or smart phone access to complete REDCap survey.
Access to smart phone app to upload WatchPAT data.

Exclusion Criteria:

< 18 years of age.
Current pregnancy.
Patients with previous diagnosis of sleep apnea.

Eligibility last updated 1/11/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Jacqueline Squire, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Jacqueline Squire, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials